There have been five different insiders buying Transition Therapeutics and there have not been any insiders selling Transition Therapeutics during the last 30 days. Four of these five insiders increased their holdings by more than 10%. Transition Therapeutics has an insider ownership of 5.09%.

The five insiders purchased their shares at $5.32. I believe Transition Therapeutics could be a good pick below $5.32 based on the intensive insider buying.

Click to enlarge

(Source: Investor presentation)

Disclosure: The author has no positions in any stocks mentioned, but may initiate a long position in TTHI over the next 72 hours. The author wrote this article themselves, and it expresses their own opinions. The author is not receiving compensation for it (other than from Seeking Alpha). The author has no business relationship with any company whose stock is mentioned in this article.